{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:02:24Z","timestamp":1782442944710,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["Z171100001117026"],"award-info":[{"award-number":["Z171100001117026"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Primary aldosteronism (PA) increases the risk of cardiovascular morbidity, including stroke, coronary artery disease, atrial fibrillation, and heart failure. The relationship between primary aldosteronism and aortic dissection has rarely been reported. We report a case of aortic dissection caused by secondary hypertension from PA and review similar cases in the literature.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 56-year-old woman with a history of surgery for aortic dissection presented for follow-up of hypertension and a left adrenal mass. She had been diagnosed with hypertension and hypokalemia in 2003. Blood pressure had been controlled by antihypertensive medications. In 2009, she presented with chest and back pain; she was diagnosed with aortic dissection by computed tomography (CT). She underwent placement of an endovascular aortic stent graft. CT at that time showed a left adrenal mass with a diameter of 1\u2009cm. In 2017, CT reexamination revealed that the left adrenal mass had grown to 3\u2009cm in diameter. Laboratory data showed blood potassium 2.4\u2009mmol\/L (reference range: 3.5\u20135.3\u2009mmol\/L). The plasma aldosterone\/renin ratio was elevated because of suppressed plasma renin and elevated serum aldosterone levels. Plasma aldosterone levels were not suppressed after taking captopril. Positron emission tomography\/CT showed that the left adrenal tumor radiographic uptake was slightly increased (maximum standardized uptake value of 2.2), and metastasis was not detected. Laparoscopic adrenalectomy was performed, and an adrenocortical adenoma was confirmed histopathologically. After surgery, blood pressure and laboratory findings were within their reference ranges without any pharmacological treatment.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our patient and the literature suggest that PA is a potential cause of aortic dissection. Diagnosing PA in the early stages of the disease and early treatment are important because affected patients may be at increased risk of aortic dissection.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12902-020-00601-9","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T09:03:44Z","timestamp":1596186224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Is primary aldosteronism a potential risk factor for aortic dissection? A case report and literature review"],"prefix":"10.1186","volume":"20","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-7972","authenticated-orcid":false,"given":"Fang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianliang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"issue":"8","key":"601_CR1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","volume":"138","author":"JB Byrd","year":"2018","unstructured":"Byrd JB, Turcu AF, Auchus RJ. Primary aldosteronism. Circulation. 2018;138(8):823\u201335.","journal-title":"Circulation."},{"issue":"5","key":"601_CR2","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9628","key":"601_CR3","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","volume":"371","author":"S Douma","year":"2008","unstructured":"Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008;371(9628):1921\u20136.","journal-title":"Lancet"},{"issue":"1","key":"601_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D'Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41\u201350.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"14","key":"601_CR5","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69(14):1811\u201320.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"601_CR6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/HYPERTENSIONAHA.118.12342","volume":"74","author":"C-S Hung","year":"2019","unstructured":"Hung C-S, Sung S-H, Liao C-W, Pan C-T, Chang C-C, Chen Z-W, et al. Aldosterone induces vascular damage. Hypertension. 2019;74(3):623\u20139.","journal-title":"Hypertension"},{"issue":"1","key":"601_CR7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MNH.0000000000000189","volume":"25","author":"JM Luther","year":"2016","unstructured":"Luther JM. Aldosterone in vascular and metabolic dysfunction. Curr Opin Nephrol Hypertens. 2016;25(1):16\u201321.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"601_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","volume":"42","author":"L Mosso","year":"2003","unstructured":"Mosso L, Carvajal C, Gonz\u00e1lez A, Barraza A, Avila F, Montero J, et al. Primary aldosteronism and hypertensive disease. Hypertension. 2003;42(2):161\u20135.","journal-title":"Hypertension"},{"issue":"3","key":"601_CR9","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","volume":"60","author":"M Reincke","year":"2012","unstructured":"Reincke M, Fischer E, Gerum S, Merkle K, Schulz S, Pallauf A, et al. Observational study mortality in treated primary aldosteronism: the german conn\u2019s registry. Hypertension. 2012;60(3):618\u201324.","journal-title":"Hypertension"},{"issue":"22","key":"601_CR10","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.jacc.2019.09.057","volume":"74","author":"GP Rossi","year":"2019","unstructured":"Rossi GP. Primary aldosteronism: Jacc state-of-the-art review. J Am Coll Cardiol. 2019;74(22):2799\u2013811.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"601_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s13105-017-0600-2","volume":"74","author":"Y Yan","year":"2018","unstructured":"Yan Y, Wang C, Lu Y, Gong H, Wu Z, Ma X, et al. Mineralocorticoid receptor antagonism protects the aorta from vascular smooth muscle cell proliferation and collagen deposition in a rat model of adrenal aldosterone-producing adenoma. J Physiol Biochem. 2018;74(1):17\u201324.","journal-title":"J Physiol Biochem"},{"issue":"3","key":"601_CR12","first-page":"470","volume":"63","author":"G Zavatta","year":"2019","unstructured":"Zavatta G, Di Dalmazi G, Pizzi C, Bracchetti G, Mosconi C, Balacchi C, et al. Larger ascending aorta in primary aldosteronism: a 3-year prospective evaluation of adrenalectomy vs. Med Treatment Endocrine. 2019;63(3):470\u20135.","journal-title":"Med Treatment Endocrine"},{"key":"601_CR13","doi-asserted-by":"crossref","first-page":"16053","DOI":"10.1038\/nrdp.2016.53","volume":"2","author":"CA Nienaber","year":"2016","unstructured":"Nienaber CA, Clough RE, Sakalihasan N, Suzuki T, Gibbs R, Mussa F, et al. Aortic dissection. Nat Rev Dis Primers. 2016;2:16053.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"601_CR14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1536\/ihj.24.995","volume":"24","author":"A Shimizu","year":"1983","unstructured":"Shimizu A, Aoi W, Akahoshi M, Utsunomiya T, Doi Y, Suzuki S, et al. Elevation of plasma renin activity during pregnancy and rupture of a dissecting aortic aneurysm in a patient with primary aldosteronism. Jpn Heart J. 1983;24(6):995\u20131006.","journal-title":"Jpn Heart J"},{"issue":"3","key":"601_CR15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF02738886","volume":"10","author":"K-Y Lam","year":"1999","unstructured":"Lam K-Y, Lo C-Y. The clinicopathologic significance of unilateral adrenal cortical hyperplasia: report of an unusual case and a review of the literature. Endocr Pathol. 1999;10(3):243\u20139.","journal-title":"Endocr Pathol"},{"issue":"6","key":"601_CR16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/000331979905000609","volume":"50","author":"AM Safi","year":"1999","unstructured":"Safi AM, Kwan T, Afflu E, Alam M, Anderson JE, Clark LT. Coronary artery aneurysms, aortic dissection, and hypertension secondary to primary aldosteronism: a rare triad. A case report. Angiology. 1999;50(6):503\u20138.","journal-title":"Angiology"},{"issue":"1","key":"601_CR17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000095787","volume":"108","author":"SH Ahmed","year":"2007","unstructured":"Ahmed SH, Husain NM, Khawaja SN, Massey CV, Pettyjohn FS. Is primary hyperaldosteronism a risk factor for aortic dissection? Cardiology. 2007;108(1):48\u201350.","journal-title":"Cardiology"},{"issue":"3","key":"601_CR18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ejvsextra.2010.05.004","volume":"20","author":"KL Harvey","year":"2010","unstructured":"Harvey KL, Riga C, Oconnor M, Hamady M, Chapman N, Gibbs RGJ. A rare case of aortic dissection and primary hyperaldosteronism. Ejves Extra. 2010;20(3):546.","journal-title":"Ejves Extra"},{"issue":"5","key":"601_CR19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11748-009-0417-1","volume":"58","author":"H Hirai","year":"2010","unstructured":"Hirai H, Shibata T, Sasaki Y, Fujii H, Kubo S, Suehiro S. Simultaneous surgery for chronic aortic dissection and adrenal adenoma with primary aldosteronism. Gen Thorac Cardiovasc Surg. 2010;58(5):235\u20138.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"601_CR20","doi-asserted-by":"crossref","unstructured":"Shahrrava A, Moinuddin S, Boddu P, Shah R. A case of glucocorticoid remediable aldosteronism and thoracoabdominal aneurysms. Case Rep Endocrinol 2016, 2016:2017571.","DOI":"10.1155\/2016\/2017571"},{"issue":"9","key":"601_CR21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/eurheartj\/ehx319","volume":"39","author":"E Bossone","year":"2018","unstructured":"Bossone E, LaBounty TM, Eagle KA. Acute aortic syndromes: Diagnosis and management, an update. Eur Heart J. 2018;39(9):739\u201349d.","journal-title":"Eur Heart J"},{"issue":"11","key":"601_CR22","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1097\/HJH.0b013e328330a963","volume":"27","author":"E Leibovitz","year":"2009","unstructured":"Leibovitz E, Ebrahimian T, Paradis P, Schiffrin EL. Aldosterone induces arterial stiffness in absence of oxidative stress and endothelial dysfunction. J Hypertens. 2009;27(11):2192\u2013200.","journal-title":"J Hypertens"},{"issue":"2","key":"601_CR23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.111.181123","volume":"59","author":"DA Kasal","year":"2012","unstructured":"Kasal DA, Barhoumi T, Li MW, Yamamoto N, Zdanovich E, Rehman A, et al. T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension. 2012;59(2):324\u201330.","journal-title":"Hypertension"},{"issue":"23","key":"601_CR24","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/CIRCULATIONAHA.116.024369","volume":"134","author":"T Bruder-Nascimento","year":"2016","unstructured":"Bruder-Nascimento T, Ferreira NS, Zanotto CZ, Ramalho F, Pequeno IO, Olivon VC, et al. Nlrp3 inflammasome mediates aldosterone-induced vascular damage. Circulation. 2016;134(23):1866\u201380.","journal-title":"Circulation"},{"key":"601_CR25","first-page":"153","volume":"6","author":"ME Moss","year":"2015","unstructured":"Moss ME, Jaffe IZ. Mineralocorticoid receptors in the pathophysiology of vascular inflammation and atherosclerosis. Front Endocrinol. 2015;6:153.","journal-title":"Front Endocrinol"},{"issue":"1","key":"601_CR26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.HYP.0000078357.92682.EC","volume":"42","author":"Q Pu","year":"2003","unstructured":"Pu Q, Neves MF, Virdis A, Touyz RM, Schiffrin EL. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension. 2003;42(1):49\u201355.","journal-title":"Hypertension"},{"issue":"1","key":"601_CR27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/1573402113666170228151402","volume":"13","author":"S Chrissobolis","year":"2017","unstructured":"Chrissobolis S. Vascular consequences of aldosterone excess and mineralocorticoid receptor antagonism. Curr Hypertens Rev. 2017;13(1):46\u201356.","journal-title":"Curr Hypertens Rev"},{"issue":"4","key":"601_CR28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","volume":"40","author":"A Virdis","year":"2002","unstructured":"Virdis A, Neves MF, Amiri F, Viel E, Touyz RM, Schiffrin EL. Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension. 2002;40(4):504\u201310.","journal-title":"Hypertension"},{"issue":"6","key":"601_CR29","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/01.HYP.37.6.1444","volume":"37","author":"JB Park","year":"2001","unstructured":"Park JB, Schiffrin EL. Et(a) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats. Hypertension. 2001;37(6):1444\u20139.","journal-title":"Hypertension"},{"issue":"5","key":"601_CR30","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.113.01803","volume":"63","author":"AJ Rickard","year":"2014","unstructured":"Rickard AJ, Morgan J, Chrissobolis S, Miller AA, Sobey CG, Young MJ. Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone\/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure. Hypertension. 2014;63(5):1033\u201340.","journal-title":"Hypertension"},{"issue":"2","key":"601_CR31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/ATVBAHA.113.302854","volume":"34","author":"D Pruthi","year":"2014","unstructured":"Pruthi D, McCurley A, Aronovitz M, Galayda C, Karumanchi SA, Jaffe IZ. Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors. Arterioscler Thromb Vasc Biol. 2014;34(2):355\u201364.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"601_CR32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.mvr.2006.12.001","volume":"73","author":"CS Rigsby","year":"2007","unstructured":"Rigsby CS, Pollock DM, Dorrance AM. Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats. Microvasc Res. 2007;73(3):198\u2013205.","journal-title":"Microvasc Res"},{"issue":"6","key":"601_CR33","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ajh.2011.20","volume":"24","author":"CS Rigsby","year":"2011","unstructured":"Rigsby CS, Ergul A, Portik Dobos V, Pollock DM, Dorrance AM. Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension. Am J Hypertens. 2011;24(6):708\u201315.","journal-title":"Am J Hypertens"},{"issue":"18","key":"601_CR34","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","volume":"105","author":"S Rajagopalan","year":"2002","unstructured":"Rajagopalan S, Duquaine D, King S, Pitt B, Patel P. Mineralocorticoid receptor antagonism in experimental atherosclerosis. Circulation. 2002;105(18):2212\u20136.","journal-title":"Circulation"},{"issue":"6","key":"601_CR35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/FJC.0b013e31826f5535","volume":"60","author":"A Raz-Pasteur","year":"2012","unstructured":"Raz-Pasteur A, Gamliel-Lazarovich A, Coleman R, Keidar S. Eplerenone reduced lesion size in early but not advanced atherosclerosis in apolipoprotein e-deficient mice. J Cardiovasc Pharmacol. 2012;60(6):508\u201312.","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-020-00601-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-020-00601-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-020-00601-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T23:30:40Z","timestamp":1627687840000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-020-00601-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["601"],"URL":"https:\/\/doi.org\/10.1186\/s12902-020-00601-9","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"assertion":[{"value":"27 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}